Euglycemic diabetic ketoacidosis of unknown Etiology in a type 2 diabetic patient

被引:0
作者
Villegas, Katrina J. [1 ]
Guerrero, Laura [2 ]
Moussa, Hala [1 ]
Rajab, Islam [1 ]
Rezkalla, Abraam [1 ]
Patel, Dhruv [1 ]
Qarqash, Mohammed A. [3 ]
机构
[1] St Josephs Univ, Med Ctr, Dept Internal Med, Paterson, NJ USA
[2] Bergen New Bridge Med Ctr, Dept Psychiat, Paramus, NJ USA
[3] An Najah Natl Univ, Dept Med, Nablus, Palestine
关键词
Euglycemic diabetic ketoacidosis; atypical DKA; metabolic acidosis without hyperglycemia; insulin-dependent diabetes complications; SGLT2 inhibitor-independent DKA; chronic kidney disease; MANAGEMENT; ADULTS;
D O I
10.1093/omcr/omaf057
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Euglycemic diabetic ketoacidosis is a rare form of DKA characterized by severe ketosis and metabolic acidosis without marked hyperglycemia. We report a 45-year-old female with insulin-dependent diabetes and chronic kidney disease, initially presenting with acute heart failure, who later developed euglycemic DKA. Despite near-normal glucose levels, high anion gap metabolic acidosis with significant ketones highlighted this crisis. Treatment included fluids, insulin with dextrose, and intensive monitoring. This case underscores the need for early recognition of euglycemic DKA, especially in complex patients, to improve outcomes.
引用
收藏
页数:3
相关论文
共 9 条
[1]   SALUTARY EFFECTS OF MODEST FLUID REPLACEMENT IN THE TREATMENT OF ADULTS WITH DIABETIC-KETOACIDOSIS - USE IN PATIENTS WITHOUT EXTREME VOLUME DEFICIT [J].
ADROGUE, HJ ;
BARRERO, J ;
EKNOYAN, G .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (15) :2108-2113
[2]  
Braund K., 2002, Endogenous Metabolic Disorders
[3]   Controversies in the management of hyperglycaemic emergencies in adults with diabetes [J].
Cardoso, Luis ;
Vicente, Nuno ;
Rodrigues, Dircea ;
Gomes, Leonor ;
Carrilho, Francisco .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 68 :43-54
[4]   REVIEW: Practical strategies to maintain anabolism by intravenous nutritional management in children with inborn metabolic diseases [J].
Kripps, Kimberly A. ;
Baker, Peter R., II ;
Thomas, Janet A. ;
Skillman, Heather E. ;
Bernstein, Laurie ;
Gaughan, Sommer ;
Burns, Casey ;
Coughlin, Curtis R., II ;
McCandless, Shawn E. ;
Larson, Austin A. ;
Kochar, Aaina ;
Stillman, Chelsey F. ;
Wymore, Erica M. ;
Hendricks, Ellie G. ;
Woontner, Michael ;
Van Hove, Johan L. K. .
MOLECULAR GENETICS AND METABOLISM, 2021, 133 (03) :231-241
[5]  
Modi A, 2017, CURR DIABETES REV, V13, P315, DOI 10.2174/1573399812666160421121307
[6]  
Ng KE., U.S. Pharmacist, V46
[7]  
Plewa MC, 2025, StatPearls
[8]   Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors [J].
Rosenstock, Julio ;
Ferrannini, Ele .
DIABETES CARE, 2015, 38 (09) :1638-1642
[9]   Hyperglycaemic crises in adults with diabetes: a consensus report [J].
Umpierrez, Guillermo E. ;
Davis, Georgia M. ;
Elsayed, Nuha A. ;
Fadini, Gian Paolo ;
Galindo, Rodolfo J. ;
Hirsch, Irl B. ;
Klonoff, David C. ;
McCoy, Rozalina G. ;
Misra, Shivani ;
Gabbay, Robert A. ;
Bannuru, Raveendhara R. ;
Dhatariya, Ketan K. .
DIABETOLOGIA, 2024, 67 (08) :1455-1479